Team

He is also the Chairman of Health and Plant Protein Group (ASX:HPP) and formerly a Board Director of eCargo Holdings (ASX:ECG)

Mr. Lin was a Partner of BDO Australia and the firm’s China Advisory Services national leader between 2009 and 2018. During his tenure as a Partner of BDO, he advised on commercial aspects of transactions and acted as the lead advisor to foreign investors on mergers and acquisitions and capital market activities, with a strong focus on the food, agribusiness, and technology sectors.

Mr. Lin was previously a specialist tax practitioner for over 10 years with Mallesons, PricewaterhouseCoopers, and Deloitte.

Mr. Lin received his Graduate Diploma in Applied Finance from Securities Institute of Australia and bachelor’s degrees in Commerce and Laws from The University of Queensland. He is a Member of Chartered Accountants Australia & New Zealand and a Solicitor of the Supreme Court of Queensland. He remains a current practitioner of both professions.

Prior to Isola Capital, he spent seven years at Olympus Capital, a pan-Asian private equity fund founded in 1997, where he was Director focused on both minority and control investments in the food, agribusiness, financial services, and industrial sectors in Greater China and Korea.

Before transitioning to private equity, Mr. Wu started his career in investment banking with ING Barings and Citigroup. During his investment banking career, he developed broad M&A advisory, leveraged buyout, and capital markets expertise in food and beverage, retail, financial services, and technology sectors across the region.

Mr. Wu received his MBA from NYU Stern School of Business and BBA in Finance from National Taiwan University.

Previously, Mr. Wang was Vice President of Cosmos Vacuum Technology Corp., a technology company with operations in Greater China. During his 10-year tenure with Cosmos Vacuum Technology, he was in charge of overall operations and the finance department. Mr. Wang started his career as an Auditor in Deloitte.

Mr. Wang received his MBA from University of Houston and BBA in Accounting from National Taiwan University. He passed CPA exams in Taiwan and the U.S.

Peter serves as Chairman Asia Pacific for US probiotic company Seed Health Inc., is an External Advisor for Bain & Company, sits on the Advisory Board of the Australia-China Research Institute and is a Director of the Dorji Lingpa Foundation in Bhutan.

From 2009 to February 2020 Peter was Managing Director Asia for Blackmores Limited, Australia’s leading ASX listed natural healthcare company. Peter was responsible for growing Blackmores’ Asia business to over A$ 200 million, and employing 1,000 staff in subsidiary companies in Singapore, Thailand, Malaysia, Taiwan, Hong Kong, Korea and China, joint venture in Indonesia, distribution partnerships in Japan, Vietnam, Kazakhstan and Pakistan and overall strategy for Blackmores’ growth objectives in Asia.

Prior to working for Blackmores, Peter was Australia’s most senior trade diplomat in China as the Minister (Commercial) in the Australian Embassy Beijing. Peter also previously held Australia’s Senior Trade Commissioner positions in Shanghai, Hong Kong and Taipei, was the Trade & Investment Director of the South Pacific Forum Secretariat in Fiji and also served as the South Pacific Expert Adviser on trade development to the United Nations Conference on Trade and Development (UNCTAD), and the UN Commission for Sustainable Development.

In June 2017 Peter was appointed as Vice Chairman of the China Association for Quality Inspection (CAQI) Advisory Committee – the first and only foreign citizen to hold a CAQI committee position. CAQI is a high-level non-profit Chinese organisation with responsibility for product quality inspection under the supervision of China’s State Administration for Market Regulation.